|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00809 GLOBAL BIO-CHEM
Nominal 
0.068 +0.001 (+1.493%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 1,373,938 | 269.062% | 372,278 | 746,551 | 848,867 | 4,561,391 |
| Cost of Sales | (1,330,301) | 293.952% | (337,681) | (698,200) | (774,767) | (4,357,862) |
| Gross Profit | 43,637 | 26.129% | 34,597 | 48,351 | 74,100 | 203,529 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | 5,008,064 | -- | -- | -- | (728,190) | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (2,004) | (2,332) | (1,541) | |
| Profit / (Loss) before Taxation | 3,701,045 | -- | (1,573,784) | (409,469) | (2,410,926) | (1,076,617) | |
| Taxation | 42,082 | -22.385% | 54,219 | (25,920) | (22,340) | (39,717) | |
| Profit / (Loss) from Discontinued Operations | 481,466 | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 76,497 | 34,588 | 3,317 | 48,515 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 4,224,593 | -- | (1,443,068) | (400,801) | (2,429,949) | (1,067,819) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 750,348 | 3.329% | 726,173 | 790,314 | 724,423 | 603,076 |
| Depreciation & Amortisation | 243,563 | -26.307% | 330,509 | 402,513 | 456,928 | 504,951 |
| Directors' Emoluments | 1,246 | -12.806% | 1,429 | 1,685 | 1,597 | 1,707 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Disclaimer | Disclaimer | Disclaimer | Disclaimer |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 47.400 | -- | -16.200 | -4.500 | -28.600 | -15.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.006) | -- | (0.010) | (0.053) | (0.003) | 0.059 |
| NBV per share ($) | (0.453) | -- | (0.846) | (0.732) | (0.658) | (0.547) |
| Remarks: | Real time quote last updated: 06/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -157,743,000 |
| %Change | 143.040% |
| EPS / (LPS) | HKD -0.018 |
| NBV Per Share ($) | HKD -0.497 |